HOME
CAREERS
CONTACT US
PRIVACY POLICY
About
Team
Services
Clients
Execution Driven Corporate Advisory & Investor Relations
Newsroom
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Thursday May 16, 2024
Is Bluebird Bio Stock a Buy?
Thursday May 16, 2024
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
Thursday May 16, 2024
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Saturday May 11, 2024